GrainCorp's earnings are heavily influenced by events outside its control, so do we rate the company a buy, hold or sell?
Shares
With August reporting season underway, we explain why annual reports are important, and the big names to watch.
There is an old saying that if all you have is a hammer then everything looks like a nail, which is appropriate as the RBA attempts to adjust the economy.
Retail spending is up 12% on this time last year, but can it last? And what does it mean for the ASX? Here's our market wrap.
Despite a strong start to the year, companies listing on the ASX for the first time have been hit by the broader share market downturn, creating concerns for investors.
For investors keen to protect their capital, now is not a prudent time to be overly concentrated in backing Australia's big banks.
Sims Limited should be at the top of the list for investors looking to gain exposure to companies that participate in the circular economy.
Gold is often touted as a hedge against inflation and a defensive asset in volatile markets, so should investors be buying physical gold or gold stocks?
Our hot stock of the week, Neuren Pharmaceuticals, could soon be one of a handful of ASX-listed companies with an FDA-approved drug.
The demand for electric vehicles is outstripping supply, yet lithium stocks have continued to fall. Does this spell opportunity for investors?